Fairpointe Capital Has Trimmed By $60.70 Million Its Varian Medical Systems (VAR) Stake; Managed Asset Portfolios Lifted Nokia (NOK) Position

December 7, 2017 - By Michael Collier

Managed Asset Portfolios Llc increased Nokia Corp (NOK) stake by 69.93% reported in 2017Q2 SEC filing. Managed Asset Portfolios Llc acquired 557,750 shares as Nokia Corp (NOK)’s stock rose 22.38%. The Managed Asset Portfolios Llc holds 1.36M shares with $8.35 million value, up from 797,595 last quarter. Nokia Corp now has $26.07B valuation. The stock decreased 1.69% or $0.08 during the last trading session, reaching $4.64. About 11.55 million shares traded. Nokia Corporation (NYSE:NOK) has risen 19.54% since December 7, 2016 and is uptrending. It has outperformed by 2.84% the S&P500.

Fairpointe Capital Llc decreased Varian Medical Systems (VAR) stake by 29.55% reported in 2017Q2 SEC filing. Fairpointe Capital Llc sold 589,353 shares as Varian Medical Systems (VAR)’s stock rose 13.68%. The Fairpointe Capital Llc holds 1.41 million shares with $144.99M value, down from 1.99M last quarter. Varian Medical Systems now has $10.28 billion valuation. The stock increased 1.04% or $1.16 during the last trading session, reaching $112.2. About 167,067 shares traded. Varian Medical Systems, Inc. (NYSE:VAR) has risen 29.46% since December 7, 2016 and is uptrending. It has outperformed by 12.76% the S&P500.

Since June 8, 2017, it had 0 insider purchases, and 3 insider sales for $272,178 activity. The insider GUERTIN TIMOTHY E sold 16,000 shares worth $1.65 million. LARET MARK R had sold 1,428 shares worth $147,761. $87,378 worth of Varian Medical Systems, Inc. (NYSE:VAR) shares were sold by KUO JOHN W. $110,000 worth of Varian Medical Systems, Inc. (NYSE:VAR) was sold by KENNEDY KOLLEEN T on Monday, June 12.

Investors sentiment increased to 0.95 in Q2 2017. Its up 0.04, from 0.91 in 2017Q1. It increased, as 33 investors sold VAR shares while 184 reduced holdings. 74 funds opened positions while 133 raised stakes. 90.12 million shares or 0.48% more from 89.68 million shares in 2017Q1 were reported. Hexavest owns 2,023 shares for 0% of their portfolio. The Germany-based Deutsche National Bank Ag has invested 0.02% in Varian Medical Systems, Inc. (NYSE:VAR). Schaper Benz & Wise Inv Counsel Wi has invested 1.98% in Varian Medical Systems, Inc. (NYSE:VAR). Chevy Chase, a Maryland-based fund reported 79,228 shares. Moreover, Gateway Invest Advisers Limited Liability Corp has 0.01% invested in Varian Medical Systems, Inc. (NYSE:VAR). Jlb & Assoc Incorporated holds 1.98% or 75,620 shares. Neuberger Berman Grp Lc stated it has 0.02% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Koch Indus invested in 0.36% or 1.33 million shares. Riverhead Cap Management Limited Liability accumulated 13,028 shares or 0.07% of the stock. Wealth Architects reported 0.58% in Varian Medical Systems, Inc. (NYSE:VAR). Estabrook Cap Management reported 0% of its portfolio in Varian Medical Systems, Inc. (NYSE:VAR). Price T Rowe Associate Md reported 166,480 shares. Cornerstone Cap Mgmt Hldgs Limited Liability has 0.02% invested in Varian Medical Systems, Inc. (NYSE:VAR). Pggm, a Netherlands-based fund reported 123,038 shares. Amica Pension Fund Board Of Trustees has 0.06% invested in Varian Medical Systems, Inc. (NYSE:VAR) for 4,387 shares.

Among 11 analysts covering Varian Medical Systems Inc. (NYSE:VAR), 3 have Buy rating, 1 Sell and 7 Hold. Therefore 27% are positive. Varian Medical Systems Inc. had 30 analyst reports since August 27, 2015 according to SRatingsIntel. The stock of Varian Medical Systems, Inc. (NYSE:VAR) has “Buy” rating given on Friday, July 14 by Jefferies. RBC Capital Markets initiated Varian Medical Systems, Inc. (NYSE:VAR) on Tuesday, December 22 with “Sector Perform” rating. The rating was maintained by Robert W. Baird with “Neutral” on Wednesday, September 28. As per Friday, September 1, the company rating was maintained by RBC Capital Markets. On Monday, August 28 the stock rating was maintained by Robert W. Baird with “Hold”. The stock of Varian Medical Systems, Inc. (NYSE:VAR) earned “Neutral” rating by BTIG Research on Thursday, September 7. Barrington Research reinitiated Varian Medical Systems, Inc. (NYSE:VAR) rating on Tuesday, January 12. Barrington Research has “Outperform” rating and $91 target. The rating was maintained by Brean Capital on Thursday, April 28 with “Buy”. Citigroup maintained Varian Medical Systems, Inc. (NYSE:VAR) rating on Monday, October 30. Citigroup has “Neutral” rating and $121 target. The firm earned “Hold” rating on Monday, October 2 by RBC Capital Markets.

Fairpointe Capital Llc increased Mattel (NASDAQ:MAT) stake by 1.56 million shares to 7.99M valued at $172.10M in 2017Q2. It also upped Chicago Bridge & Iron (NYSE:CBI) stake by 1.20 million shares and now owns 4.05M shares. Cooper Tire & Rubber Co. (NYSE:CTB) was raised too.

Analysts await Varian Medical Systems, Inc. (NYSE:VAR) to report earnings on January, 24. They expect $0.99 EPS, up 32.00% or $0.24 from last year’s $0.75 per share. VAR’s profit will be $90.70M for 28.33 P/E if the $0.99 EPS becomes a reality. After $1.09 actual EPS reported by Varian Medical Systems, Inc. for the previous quarter, Wall Street now forecasts -9.17% negative EPS growth.

Among 24 analysts covering Nokia (NYSE:NOK), 11 have Buy rating, 3 Sell and 10 Hold. Therefore 46% are positive. Nokia had 46 analyst reports since August 26, 2015 according to SRatingsIntel. Charter Equity downgraded the stock to “Hold” rating in Tuesday, October 31 report. On Wednesday, July 5 the stock rating was maintained by Credit Suisse with “Buy”. The rating was upgraded by Danske Bank on Wednesday, August 26 to “Hold”. As per Thursday, July 27, the company rating was maintained by Canaccord Genuity. Danske Bank downgraded Nokia Corporation (NYSE:NOK) on Wednesday, January 25 to “Sell” rating. Nordea upgraded Nokia Corporation (NYSE:NOK) on Friday, April 8 to “Buy” rating. Cowen & Co maintained Nokia Corporation (NYSE:NOK) on Thursday, October 19 with “Hold” rating. The rating was upgraded by Bank of America on Friday, May 13 to “Buy”. The firm earned “Buy” rating on Monday, May 16 by Canaccord Genuity. The stock has “Neutral” rating by Bank of America on Tuesday, November 15.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com